People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

The phase 3 STEP UP trial enrolled 1407 adults aged 18 years and older with a body mass index of at least 30kg/m2 and without diabetes.

Novo Nordisk (NVO) announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a ...

Users of weight-loss drugs are seeking help from dermatologists to rectify ‘facial sagging’ after shedding the pounds ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of the active ingredient semaglutide, used in its ...

Since semaglutide has shown effectiveness in reducing body weight for those with overweight or obesity, Ozempic may also aid in weight loss. However, Ozempic itself is not FDA approved to treat ...

Olivia Petter talks to experts who say that people with eating disorders are especially vulnerable to the allure of ‘quick ...

(WDRB) -- A nationwide shortage of popular weight loss medications has patients searching ... The FDA also warned consumers not to use counterfeit semaglutide in 2023. "There are definitely ...

Ozempic and Wegovy have the same active ingredient, semaglutide. Wegovy has been approved by the Food and Drug Administration (FDA) for weight loss. Ozempic has been approved for diabetes, though it's ...